Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Clinical trial NCT05263934 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05263934
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2026-09-29
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.